Request for Covid-19 Impact Assessment of this Report

Take Action
Healthcare

Global Retinal Disorder Treatment Market Size study, by Disease Indication (Macular Degeneration, Diabetic Retinopathy, Diabetic Macular Edema, Others (Retinal Vein Occlusion, etc.)), by Therapeutic Class (Anti-VEGF Agents, Others (Anti-inflammatory Drugs, etc.)), by Dosage Form (Gels, Eye Solutions, Capsules & Tablets, Eye Drops, Ointments), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Sales) and Regional Forecasts 2019-2026

  • BIZ3460429
  • 200 Pages
  • January 2020
  • Healthcare
Download Sample    Get Discount   
 
Global Retinal Disorder Treatment Market is valued approximately at USD 8.73 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 8.10% over the forecast period 2019-2026. Retina is a thin membranous lining at the back of the eye. It is a light sensitive nerve tissue on which the images focused and converted into electrical impulses which are carried to the brain via optic nerve. Retinal disorders affect the important tissues of the eye and can even cause temporary to permanent blindness. According to World Health Organization 2019, over 295 million people are visually impaired worldwide of which 39 million are blind. Further, retinal diseases are the most common cause of childhood blindness across the globe. Some of these children are blinded by inherited retinal diseases (IRD) like retinitis pigmentosa (incurable) while many of them can have retinopathy of prematurity (curable). Growing retinal diseases worldwide calls for the need of affordable and effective treatment alternatives which in turn will drive the global retinal disorder treatment market. Also, technical advancements, new product launches, collaborations and other strategies being executed by the major players is anticipated to provide low cost and effective retinal disorder treatment and hence fuel the market growth. Moreover, government and other nonprofit organizations are increasing spending on the treatment of retinal disorder treatments. For instance, The Foundation Fighting Blindness, a nonprofit organization established on 1971, is leading a collaborative effort among scientists, patients, their families and the commercial sector to propel the development of preventions, treatments, and cures for inherited retinal diseases (IRDs). Therefore, rising awareness, collaborative efforts and initiatives by the key players are the factors likely to create growth opportunities to the retinal disorder treatment market over the forecast period.

The regional analysis of global Retinal Disorder Treatment Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the presence of key market players in the region. Also, increasing prevalence of retinal disorders is expected to fuel the regional growth. However, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as rising awareness about early diagnosis, high unmet clinical needs and availability of effective treatment methods are responsible for the high CAGR of the region over the forecast period.

Major market player included in this report are:

Santen Pharmaceutical Co., Ltd.

Regeneron Pharmaceuticals, Inc.

F. Hoffmann-La Roche Ltd.

Pfizer, Inc.

Allergan plc

Shire (Takeda Pharmaceutical Company Limited)

Bayer AG

Graybug Vision, Inc.

Novartis AG

Acucela Inc. (Kubota Pharmaceutical Holdings Co., Ltd.)

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Disease Indication:

Macular Degeneration

Diabetic Retinopathy

Diabetic Macular Edema

Others (Retinal Vein Occlusion, etc.)

By Therapeutic Class:

Anti-VEGF Agents

Others (Anti-inflammatory Drugs, etc.)

By Dosage Form:

Gels

Eye Solutions

Capsules & Tablets

Eye Drops

Ointments

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Sales

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017

Base year – 2018

Forecast period – 2019 to 2026

Target Audience of the Global Retinal Disorder Treatment Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)

1.2.1. Retinal Disorder Treatment Market, by Disease Indication, 2017-2026 (USD Billion)

1.2.2. Retinal Disorder Treatment Market, by Therapeutic Class, 2017-2026 (USD Billion)

1.2.3. Retinal Disorder Treatment Market, by Dosage Form, 2017-2026 (USD Billion)

1.2.4. Retinal Disorder Treatment Market, by Distribution Channel, 2017-2026 (USD Billion)

1.2.5. Retinal Disorder Treatment Market, by Region, 2017-2026 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Retinal Disorder Treatment Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Retinal Disorder Treatment Market Dynamics

3.1. Retinal Disorder Treatment Market Impact Analysis (2018-2026)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global Retinal Disorder Treatment Market Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Retinal Disorder Treatment Market, by Disease Indication

5.1. Market Snapshot

5.2. Global Retinal Disorder Treatment Market by Disease Indication, Performance - Potential Analysis

5.3. Global Retinal Disorder Treatment Market Estimates & Forecasts by Disease Indication 2016-2026 (USD Billion)

5.4. Retinal Disorder Treatment Market, Sub Segment Analysis

5.4.1. Macular Degeneration

5.4.2. Diabetic Retinopathy

5.4.3. Diabetic Macular Edema

5.4.4. Others (Retinal Vein Occlusion, etc.)

Chapter 6. Global Retinal Disorder Treatment Market, by Therapeutic Class

6.1. Market Snapshot

6.2. Global Retinal Disorder Treatment Market by Therapeutic Class, Performance - Potential Analysis

6.3. Global Retinal Disorder Treatment Market Estimates & Forecasts by Therapeutic Class, 2016-2026 (USD Billion)

6.4. Retinal Disorder Treatment Market, Sub Segment Analysis

6.4.1. Anti-VEGF Agents

6.4.2. Others (Anti-inflammatory Drugs, etc.)

Chapter 7. Global Retinal Disorder Treatment Market, by Dosage Form

7.1. Market Snapshot

7.2. Global Retinal Disorder Treatment Market by Dosage Form, Performance - Potential Analysis

7.3. Global Retinal Disorder Treatment Market Estimates & Forecasts by Dosage Form, 2016-2026 (USD Billion)

7.4. Retinal Disorder Treatment Market, Sub Segment Analysis

7.4.1. Gels

7.4.2. Eye Solutions

7.4.3. Capsules & Tablets

7.4.4. Eye Drops

7.4.5. Ointments

Chapter 8. Global Retinal Disorder Treatment Market, by Distribution Channel

8.1. Market Snapshot

8.2. Global Retinal Disorder Treatment Market by Distribution Channel, Performance - Potential Analysis

8.3. Global Retinal Disorder Treatment Market Estimates & Forecasts by Distribution Channel, 2016-2026 (USD Billion)

8.4. Retinal Disorder Treatment Market, Sub Segment Analysis

8.4.1. Hospital Pharmacies

8.4.2. Retail Pharmacies

8.4.3. Online Sales

Chapter 9. Global Retinal Disorder Treatment Market, Regional Analysis

9.1. Retinal Disorder Treatment Market, Regional Market Snapshot

9.2. North America Retinal Disorder Treatment Market

9.2.1. U.S. Retinal Disorder Treatment Market

9.2.1.1. Disease Indication breakdown estimates & forecasts, 2016-2026

9.2.1.2. Therapeutic Class breakdown estimates & forecasts, 2016-2026

9.2.1.3. Dosage Form breakdown estimates & forecasts, 2016-2026

9.2.1.4. Distribution Channel breakdown estimates & forecasts, 2016-2026

9.2.2. Canada Retinal Disorder Treatment Market

9.3. Europe Retinal Disorder Treatment Market Snapshot

9.3.1. U.K. Retinal Disorder Treatment Market

9.3.2. Germany Retinal Disorder Treatment Market

9.3.3. Rest of Europe Retinal Disorder Treatment Market

9.4. Asia-Pacific Retinal Disorder Treatment Market Snapshot

9.4.1. China Retinal Disorder Treatment Market

9.4.2. India Retinal Disorder Treatment Market

9.4.3. Japan Retinal Disorder Treatment Market

9.4.4. Rest of Asia Pacific Retinal Disorder Treatment Market

9.5. Latin America Retinal Disorder Treatment Market Snapshot

9.5.1. Brazil Retinal Disorder Treatment Market

9.5.2. Mexico Retinal Disorder Treatment Market

9.6. Rest of The World Retinal Disorder Treatment Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies

10.2. Company Profiles

10.2.1. Santen Pharmaceutical Co., Ltd.

10.2.1.1. Key Information

10.2.1.2. Overview

10.2.1.3. Financial (Subject To Data Availability)

10.2.1.4. Sensor Type Summary

10.2.1.5. Recent Developments

10.2.2. Regeneron Pharmaceuticals, Inc.

10.2.3. F. Hoffmann-La Roche Ltd.

10.2.4. Pfizer, Inc.

10.2.5. Allergan plc

10.2.6. Shire (Takeda Pharmaceutical Company Limited)

10.2.7. Bayer AG

10.2.8. Graybug Vision, Inc.

10.2.9. Novartis AG

10.2.10. Acucela Inc. (Kubota Pharmaceutical Holdings Co., Ltd.)

Chapter 11. Research Process

11.1. Research Process

11.1.1. Data Mining

11.1.2. Analysis

11.1.3. Market Estimation

11.1.4. Validation

11.1.5. Publishing

11.2. Research Attributes

11.3. Research Assumption

List of Tables

TABLE 1. LIST OF SECONDARY EQUIPMENT TYPES, USED IN THE STUDY OF GLOBAL RETINAL DISORDER TREATMENT MARKET

TABLE 2. LIST OF PRIMARY EQUIPMENT TYPES, USED IN THE STUDY OF GLOBAL RETINAL DISORDER TREATMENT MARKET

TABLE 3. GLOBAL RETINAL DISORDER TREATMENT MARKET, REPORT SCOPE

TABLE 4. YEARS CONSIDERED FOR THE STUDY

TABLE 5. EXCHANGE RATES CONSIDERED

TABLE 6. GLOBAL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)

TABLE 7. GLOBAL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY DISEASE INDICATION 2016-2026 (USD BILLION)

TABLE 8. GLOBAL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY THERAPEUTIC CLASS 2016-2026 (USD BILLION)

TABLE 9. GLOBAL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY DOSAGE FORM 2016-2026 (USD BILLION)

TABLE 10. GLOBAL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY DISTRIBUTION CHANNEL 2016-2026 (USD BILLION)

TABLE 11. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 12. GLOBAL RETINAL DISORDER TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 13. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 14. GLOBAL RETINAL DISORDER TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 15. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 16. GLOBAL RETINAL DISORDER TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 17. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 18. GLOBAL RETINAL DISORDER TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 19. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 20. GLOBAL RETINAL DISORDER TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 21. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 22. GLOBAL RETINAL DISORDER TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 23. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 24. GLOBAL RETINAL DISORDER TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 25. U.S. RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 26. U.S. RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 27. U.S. RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 28. CANADA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 29. CANADA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 30. CANADA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 31. UK RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 32. UK RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 33. UK RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 34. GERMANY RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 35. GERMANY RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 36. GERMANY RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 37. ROE RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 38. ROE RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 39. ROE RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 40. CHINA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 41. CHINA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 42. CHINA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 43. INDIA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 44. INDIA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 45. INDIA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 46. JAPAN RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 47. JAPAN RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 48. JAPAN RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 49. ROAPAC RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 50. ROAPAC RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 51. ROAPAC RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 52. BRAZIL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 53. BRAZIL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 54. BRAZIL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 55. MEXICO RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 56. MEXICO RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 57. MEXICO RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 58. ROLA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 59. ROLA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 60. ROLA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 61. ROW RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 62. ROW RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 63. ROW RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
View Details
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
View Details
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950
View Details
 
View More
 

Client Testimonials

2026 © Copyright Big Market Research